Showing results (71-80 of 81) with videos related to
Sort By:
Pageof 9
JMIR Research Protocols|July 2, 2024
Erlotinib or Gefitinib for Treating Advanced Epidermal Growth Factor Receptor Mutation-Positive Lung Cancer in Aotearoa New Zealand: Protocol for a National Whole-of-Patient-Population Retrospective Cohort Study and Results of a Validation SubstudyPhyu Sin Aye, Joanne Barnes, George Laking, et al.Emergency Medicine Journal : EMJ|May 27, 2026
Accuracy of major trauma triage using the MATTS tool: a cohort studyGordon Fuller, James Baird, Esther Herbert, et al.Rheumatology (Oxford, England)|May 17, 2026
Prevalence of foot/ankle osteoarthritis and pain in retired male professional footballers compared to general population male controls: a cross-sectional studyAhmed Ali Thanoon, Shima Espahbodi, Monirah Ali Shuaib, et al.Rheumatology (Oxford, England)|October 21, 2025
Injury and local injection and the risk of foot/ankle osteoarthritis: a case-control study in retired UK male professional footballersAhmed Ali Thanoon, Shima Espahbodi, Monirah Ali Shuaib, et al.Bioorganic & Medicinal Chemistry Letters|August 28, 2003
Imidazo[1,2-a]pyridines: a potent and selective class of cyclin-dependent kinase inhibitors identified through structure-based hybridisationMalcolm Anderson, John F Beattie, Gloria A Breault, et al.Bioorganic & Medicinal Chemistry Letters|December 13, 2005
SAR and inhibitor complex structure determination of a novel class of potent and specific Aurora kinase inhibitorsNicola M Heron, Malcolm Anderson, David P Blowers, et al.Journal of Medicinal Chemistry|February 20, 2015
Small molecule binding sites on the Ras:SOS complex can be exploited for inhibition of Ras activationJon J G Winter, Malcolm Anderson, Kevin Blades, et al.British Journal of Sports Medicine|April 28, 2017
The Sport Concussion Assessment Tool 5th Edition (SCAT5): Background and rationaleRuben J Echemendia, Willem Meeuwisse, Paul McCrory, et al.British Journal of Sports Medicine|April 28, 2017
The Concussion Recognition Tool 5th Edition (CRT5): Background and rationaleRuben J Echemendia, Willem Meeuwisse, Paul McCrory, et al.Bioorganic & Medicinal Chemistry Letters|September 26, 2008
Imidazoles: SAR and development of a potent class of cyclin-dependent kinase inhibitorsMalcolm Anderson, David M Andrews, Andy J Barker, et al.Pageof 9